Phase I/II Study of High-Dose Calcitriol Plus Temodar for Patients With Metastatic Melanoma

NCT00301067 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Melanoma

Interventions

DIETARY_SUPPLEMENT: Calcitriol
DRUG: Temozolomide

Sponsor

Northwestern University

Collaborators

[object Object]